Hematologic Reactions
JAKAVI (ruxolitinib) safety profile – Hematologic ReactionsHematologic reactions are expected and manageable 1 ...
About Asthma
Asthma is a common chronic disease that imposes a significant burden on patients, their families and the community. 1 The World Health Organization (WHO) estimated about 383,000 asthma related deaths in 2015. 2
In...
Clinical resources
Basic Succinct Statement
We provide trustworthy information about our marketed drugs. You may view our comprehensive, up-to-date basic succinct...
Non Hematologic Reactions
JAKAVI (ruxolitinib) safety profile – Non Hematologic ReactionsWell-characterized and manageable...
About Co-Diovan®
Co-Diovan ® is a combination of Valsartan (an angiotensin receptor blocker, or ARB) and a diuretic (hydrochlorothiazide) in one convenient tablet. 1 ...
×
Ask Speakers
×